<SEC-DOCUMENT>0001193125-24-046586-index.html : 20240227
<SEC-HEADER>0001193125-24-046586.hdr.sgml : 20240227
<ACCEPTANCE-DATETIME>20240226205134
ACCESSION NUMBER:		0001193125-24-046586
CONFORMED SUBMISSION TYPE:	S-8
PUBLIC DOCUMENT COUNT:		6
FILED AS OF DATE:		20240227
DATE AS OF CHANGE:		20240226
EFFECTIVENESS DATE:		20240227

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			enGene Holdings Inc.
		CENTRAL INDEX KEY:			0001980845
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			Z4
		FISCAL YEAR END:			1031

	FILING VALUES:
		FORM TYPE:		S-8
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-277378
		FILM NUMBER:		24681530

	BUSINESS ADDRESS:	
		STREET 1:		4868 RUE LEVY, SUITE 220
		CITY:			SAINT-LAURENT
		STATE:			A8
		ZIP:			H4R 2P1
		BUSINESS PHONE:		(514) 332-4888

	MAIL ADDRESS:	
		STREET 1:		4868 RUE LEVY, SUITE 220
		CITY:			SAINT-LAURENT
		STATE:			A8
		ZIP:			H4R 2P1
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-8
<SEQUENCE>1
<FILENAME>d791601ds8.htm
<DESCRIPTION>S-8
<TEXT>
Document 1 - file: d791601ds8.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>2
<FILENAME>d791601dex51.htm
<DESCRIPTION>EX-5.1
<TEXT>
Document 2 - file: d791601dex51.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>3
<FILENAME>d791601dex231.htm
<DESCRIPTION>EX-23.1
<TEXT>
Document 3 - file: d791601dex231.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>4
<FILENAME>d791601dexfilingfees.htm
<DESCRIPTION>EX-FILING FEES
<TEXT>
Document 4 - file: d791601dexfilingfees.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>g791601g0222133736171.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 5 - file: g791601g0222133736171.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>g791601g0222133736870.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 6 - file: g791601g0222133736870.jpg

</DOCUMENT>
</SEC-DOCUMENT>